Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
Enokida Y, Shimizu K, Atsumi J, Kakegawa S, Takase Y, Kaira K, Yashima H, Araki T, Nakazawa S, Ohtaki Y, Nagashima T, Alexander L, Usui K, Ishikawa T, Hayashizaki Y, Takeyoshi I.
Enokida Y, et al. Among authors: ohtaki y.
Cancer Med. 2016 Aug;5(8):1791-801. doi: 10.1002/cam4.750. Epub 2016 May 26.
Cancer Med. 2016.
PMID: 27228500
Free PMC article.